Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We are delighted to announce that Professor Peter McCulloch of the Nuffield Department of Surgical Sciences has been awarded the title of NIHR Senior Investigator.

Professor Peter McCuloch

National Institute of Health Research (NIHR) Senior Investigators are among the most prominent and prestigious researchers funded by the NIHR and the most outstanding leaders of patient and people-based research within the NIHR research community.

Researchers are awarded this prestigious status on the basis of their internationally excellent research, its quality and volume, its relevance to patients and the public, and its impact on improvements in healthcare and public health.

Professor McCulloch founded the Quality, Reliability, Safety and Teamwork Unit (QRSTU)which is dedicated to studies of quality and safety interventions in surgery, and has worked with the NHS Institute and the Health Foundation on work to make surgery safer, and with the GMC and Oxford Patient Safety Collaborative on improving patient safety investigations. He also founded the IDEAL Collaboration, which is dedicated to improving the quality of scientific evaluation of surgery and complex treatments.

He will receive a discretionary award of £20,000 per year of appointment to fund activities that support his research, and will become a member of the college of Senior Investigators, which is maintained at around 200 researchers. 

Commenting on his award, Professor McCulloch said: “I’m delighted to receive this recognition for my work, which has focused on making surgery safer for the patient and more evidence-based. I’d like to thank the NIHR for their continuing support and all my team and collaborators for their great work.”

Read more about the Oxford academics named NIHR Senior Investigators

Similar stories

NDS project awarded Public Engagement Seed Funding 2020-21

Awards and appointments Public engagement

Seven projects from the Medical Sciences Division, including a project from the Nuffield Department of Surgical Sciences, have received funding in the 2020-21 round of the Public Engagement with Research Seed Fund for innovative projects to engage the public with medical research.

Cochrane ENT awarded NIHR funding for COVID-19 project

Awards and appointments Coronavirus COVID-19 Research

Cochrane ENT at the Nuffield Department of Surgical Sciences has been awarded funding by the National Institute for Health Research (NIHR) to complete a suite of living systematic reviews investigating the effectiveness and safety of interventions to prevent and treat loss of smell after COVID-19 infection.

Applications for Oxford-Wolfson-Marriott-Patel Scholarship now open

Awards and appointments Department Research

The Nuffield Department of Surgical Sciences (NDS) are pleased to confirm that one scholarship will be available for Home (UK) and Republic of Ireland (ROI) candidates for the DPhil in Surgical Sciences, starting in Michaelmas Term 2021.

Breast cancer study wins 2020 ONS Research Excellence Award

Awards and appointments Research

Dr Gurdeep Mannu from the Nuffield Department of Surgical Sciences, University of Oxford, has won the Office for National Statistics (ONS) Research Excellence Award for a study which highlighted early risk factors for breast cancer patients.

NDS appoints new professor to lead the way in the treatment of colorectal disease

Awards and appointments Department

Oxford University's Nuffield Department of Surgical Sciences (NDS) has appointed Mr Simon Buczacki as its first Richard Blackwell Pharsalia Professor of Colorectal Surgery.

Government boost for digitisation and AI in pathology services

Awards and appointments Clinical Women

Oxford University Hospitals (OUH) is one of the NHS trusts that will benefit from a £13.5m national funding boost to further enhance cellular pathology services and provide faster and more accurate diagnosis of deadly diseases such as cancer.